INTI
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Feb 19 closing price
Capitalization
11.36M
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
141.84M
Ad is loading...

INTI vs IVEVF

Header iconINTI vs IVEVF Comparison
Open Charts INTI vs IVEVFBanner chart's image
Inhibitor Therapeutics
Price$0.07
Change-$0.00 (-0.00%)
Volume$500
Capitalization11.36M
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization141.84M
INTI vs IVEVF Comparison Chart
Loading...
View a ticker or compare two or three
VS
INTI vs. IVEVF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INTI is a Hold and IVEVF is a Buy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (INTI: $0.07 vs. IVEVF: $2.28)
Brand notoriety: INTI and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INTI: 1% vs. IVEVF: 303%
Market capitalization -- INTI: $11.36M vs. IVEVF: $141.84M
INTI [@Biotechnology] is valued at $11.36M. IVEVF’s [@Biotechnology] market capitalization is $141.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INTI’s FA Score shows that 0 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • INTI’s FA Score: 0 green, 5 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, INTI is a better buy in the long-term than IVEVF.

Price Growth

INTI (@Biotechnology) experienced а 0.00% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

INTI is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IVEVF($142M) has a higher market cap than INTI($11.4M). INTI YTD gains are higher at: 9.692 vs. IVEVF (-37.363).
INTIIVEVFINTI / IVEVF
Capitalization11.4M142M8%
EBITDA-3.07MN/A-
Gain YTD9.692-37.363-26%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash6.38MN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
INTI: Fundamental Ratings
INTI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STGW6.300.15
+2.44%
Stagwell
HESM40.64-0.62
-1.50%
Hess Midstream LP
TSBX0.39-0.02
-4.40%
Turnstone Biologics Corp
CHWY35.12-1.81
-4.90%
Chewy
ESOA9.82-0.69
-6.57%
Energy Services of America Corp

INTI and

Correlation & Price change

A.I.dvisor tells us that INTI and QRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTI and QRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
QRON - INTI
24%
Poorly correlated
N/A
DWTX - INTI
23%
Poorly correlated
-8.84%
IVEVF - INTI
17%
Poorly correlated
N/A
IVBXF - INTI
11%
Poorly correlated
N/A
HSTC - INTI
8%
Poorly correlated
N/A
More

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with VERV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
VERV - IVEVF
46%
Loosely correlated
-7.02%
DTIL - IVEVF
32%
Poorly correlated
+0.68%
MIST - IVEVF
28%
Poorly correlated
-0.97%
AWKNF - IVEVF
25%
Poorly correlated
N/A
IDRSF - IVEVF
21%
Poorly correlated
N/A
More